Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kari Kendra

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Journal of Medical Case Reports|May 22, 2024
Local intralesional talimogene laherparepvec therapy with complete local response in oral palatine mucosal melanoma: a case reportSaurabh D Chitnis, Nolan B Seim, Kari Kendra
Journal of the National Comprehensive Cancer Network : JNCCN|December 16, 2014
Focal takotsubo cardiomyopathy with high-dose interleukin-2 therapy for malignant melanomaSenthil Damodaran, Ewa Mrozek, David Liebner, et al.
Cancers|November 11, 2022
Recent Advances in Immunotherapy for Patients with Head and Neck Cutaneous Squamous Cell CarcinomaAdam Khorasanchi, Richard Wu, Kari Kendra, et al.
Journal of Medical Case Reports|April 23, 2021
Refractory dermatitis contributed by pityriasis versicolor: a case reportMingjia Li, Natalie Spaccarelli, Kari Kendra, et al.
Oncology Research|April 3, 2026
Novel Immunotherapeutic Approaches for Patients with Head and Neck Cutaneous Squamous Cell CarcinomaAdam Khorasanchi, Merve Hasanov, Richard Wu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 14, 2015
Cotreatment of hairy cell leukemia and melanoma with the BRAF inhibitor dabrafenibJames S Blachly, Gerard Lozanski, David M Lucas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2013
Case of sorafenib-induced thyroid stormSigurdis Haraldsdottir, Quan Li, Miguel A Villalona-Calero, et al.
Histopathology|April 17, 2020
Programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in PD-1 inhibitor-associated colitis and its mimicsClarissa A Cassol, Dwight Owen, Kari Kendra, et al.
The Journal of Surgical Research|June 19, 2017
Surveillance strategies in the follow-up of melanoma patients: too much or not enough?James Kurtz, Georgia M Beasley, Doreen Agnese, et al.
Journal of the National Cancer Institute|September 2, 2004
Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapyGregory B Lesinski, Sri Vidya Kondadasula, Tim Crespin, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Journal of Medical Case Reports|May 22, 2024
Local intralesional talimogene laherparepvec therapy with complete local response in oral palatine mucosal melanoma: a case reportSaurabh D Chitnis, Nolan B Seim, Kari Kendra
Journal of the National Comprehensive Cancer Network : JNCCN|December 16, 2014
Focal takotsubo cardiomyopathy with high-dose interleukin-2 therapy for malignant melanomaSenthil Damodaran, Ewa Mrozek, David Liebner, et al.
Cancers|November 11, 2022
Recent Advances in Immunotherapy for Patients with Head and Neck Cutaneous Squamous Cell CarcinomaAdam Khorasanchi, Richard Wu, Kari Kendra, et al.
Journal of Medical Case Reports|April 23, 2021
Refractory dermatitis contributed by pityriasis versicolor: a case reportMingjia Li, Natalie Spaccarelli, Kari Kendra, et al.
Oncology Research|April 3, 2026
Novel Immunotherapeutic Approaches for Patients with Head and Neck Cutaneous Squamous Cell CarcinomaAdam Khorasanchi, Merve Hasanov, Richard Wu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 14, 2015
Cotreatment of hairy cell leukemia and melanoma with the BRAF inhibitor dabrafenibJames S Blachly, Gerard Lozanski, David M Lucas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2013
Case of sorafenib-induced thyroid stormSigurdis Haraldsdottir, Quan Li, Miguel A Villalona-Calero, et al.
Histopathology|April 17, 2020
Programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in PD-1 inhibitor-associated colitis and its mimicsClarissa A Cassol, Dwight Owen, Kari Kendra, et al.
The Journal of Surgical Research|June 19, 2017
Surveillance strategies in the follow-up of melanoma patients: too much or not enough?James Kurtz, Georgia M Beasley, Doreen Agnese, et al.
Journal of the National Cancer Institute|September 2, 2004
Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapyGregory B Lesinski, Sri Vidya Kondadasula, Tim Crespin, et al.
Pageof 7